CA2016505A1 - Preparation pharmaceutique polymerisee hydrosoluble a poids moleculaire eleve - Google Patents

Preparation pharmaceutique polymerisee hydrosoluble a poids moleculaire eleve

Info

Publication number
CA2016505A1
CA2016505A1 CA2016505A CA2016505A CA2016505A1 CA 2016505 A1 CA2016505 A1 CA 2016505A1 CA 2016505 A CA2016505 A CA 2016505A CA 2016505 A CA2016505 A CA 2016505A CA 2016505 A1 CA2016505 A1 CA 2016505A1
Authority
CA
Canada
Prior art keywords
drugs
segment
high molecular
soluble high
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2016505A
Other languages
English (en)
Other versions
CA2016505C (fr
Inventor
Yasuhisa Sakurai
Teruo Okano
Kazunori Kataoka
Noriko Yamada
Shohei Inoue
Masayuki Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Research Development Corp of Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Corp of Japan filed Critical Research Development Corp of Japan
Publication of CA2016505A1 publication Critical patent/CA2016505A1/fr
Application granted granted Critical
Publication of CA2016505C publication Critical patent/CA2016505C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
CA002016505A 1989-05-11 1990-05-10 Preparation pharmaceutique polymerisee hydrosoluble a poids moleculaire eleve Expired - Lifetime CA2016505C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP116082/1989 1989-05-11
JP1116082A JP2517760B2 (ja) 1989-05-11 1989-05-11 水溶性高分子化医薬製剤

Publications (2)

Publication Number Publication Date
CA2016505A1 true CA2016505A1 (fr) 1990-11-11
CA2016505C CA2016505C (fr) 2001-02-13

Family

ID=14678267

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002016505A Expired - Lifetime CA2016505C (fr) 1989-05-11 1990-05-10 Preparation pharmaceutique polymerisee hydrosoluble a poids moleculaire eleve

Country Status (8)

Country Link
US (2) US5412072A (fr)
EP (1) EP0397307B1 (fr)
JP (1) JP2517760B2 (fr)
KR (1) KR920006912B1 (fr)
AU (1) AU640927B2 (fr)
CA (1) CA2016505C (fr)
DE (1) DE69029006T2 (fr)
ES (1) ES2098247T3 (fr)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2517760B2 (ja) * 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
EP0452179B1 (fr) * 1990-03-28 1996-06-12 Nippon Oil And Fats Company, Limited Médicament combiné avec un polymère pour le traitement gastrique et son procédé de préparation
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
EP0665729B1 (fr) * 1992-09-04 2003-05-07 The General Hospital Corporation Polymeres biocompatibles contenant des fractions therapeutiques ou de diagnostic
US5871710A (en) * 1992-09-04 1999-02-16 The General Hospital Corporation Graft co-polymer adducts of platinum (II) compounds
WO1994008564A1 (fr) * 1992-10-08 1994-04-28 Valery Yu Alakhov Compositions d'agents antineoplasiques incorpores dans des micelles
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US5336923A (en) * 1992-12-31 1994-08-09 Honeywell, Inc. Varactor diode having a stepped capacitance-voltage profile
ES2149867T3 (es) * 1993-02-26 2000-11-16 Drug Delivery System Inst Ltd Derivados de polisacaridos y soportes para farmacos.
US5567410A (en) * 1994-06-24 1996-10-22 The General Hospital Corporation Composotions and methods for radiographic imaging
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
AU4574202A (en) * 1995-01-10 2002-07-18 Research Development Corporation Of Japan Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon
JP2690276B2 (ja) * 1995-01-10 1997-12-10 科学技術振興事業団 静電結合型高分子ミセル薬物担体とその薬剤
KR0180334B1 (ko) 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
KR100413029B1 (ko) * 1995-09-29 2004-04-30 가가쿠 기쥬츠 신코 지교단 신규안트라시클린화합물유도체및이를함유하는의약제제
DE19548114C2 (de) * 1995-12-21 2000-04-27 Deutsches Krebsforsch Konjugat, umfassend einen Wirkstoff, ein Polypeptid und einen Polyether
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
US6251959B1 (en) 1996-05-09 2001-06-26 Nippon Suisan Kaisha, Ltd. Chitin derivatives having carboxylated lower alkyl groups as hydrophilic substituents and hydrophobic substituents, and micellar aqueous composition thereof
US6617425B1 (en) * 1996-06-13 2003-09-09 Novartis Ag Peptides
US5998362A (en) * 1996-09-12 1999-12-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6391305B1 (en) 1997-09-10 2002-05-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US5939453A (en) * 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6673361B1 (en) 1999-05-19 2004-01-06 Nof Corporation Polymer, in vivo degradable material, and use
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
US7256180B2 (en) 2000-04-28 2007-08-14 Supratek Pharma Inc. Compositions and methods for inducing activation of dendritic cells
DK1286704T3 (da) * 2000-06-02 2014-09-22 Univ Texas Ethylendicystein (EC)-glucose analoge konjugater
US6338859B1 (en) * 2000-06-29 2002-01-15 Labopharm Inc. Polymeric micelle compositions
DE60121016T2 (de) * 2000-09-26 2006-12-21 Toudai Tlo, Ltd. Polymere mizelle mit darin eingeschlossenem cisplatin und ihre verwendung
US6436386B1 (en) * 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US7829074B2 (en) * 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
US20020197261A1 (en) * 2001-04-26 2002-12-26 Chun Li Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
WO2002087497A2 (fr) * 2001-04-26 2002-11-07 Board Of Regents, The University Of Texas System Compositions therapeutiques conjuguees agent/ligand, leur methodes de synthese et leur utilisation
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US7094810B2 (en) * 2001-06-08 2006-08-22 Labopharm, Inc. pH-sensitive block copolymers for pharmaceutical compositions
AU2002346296B2 (en) * 2001-06-20 2007-09-13 Nippon Kayaku Kabushiki Kaisha Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same
CA2453441C (fr) * 2001-07-13 2011-10-18 Nanocarrier Co., Ltd. Composition de lyophilisation de micelle polymere d'encapsulation de medicaments et procede de preparation associe
JP4063510B2 (ja) * 2001-07-13 2008-03-19 ナノキャリア株式会社 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤
US6592899B2 (en) 2001-10-03 2003-07-15 Macromed Incorporated PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
US7261875B2 (en) * 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
US6780324B2 (en) 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
JP2004010479A (ja) * 2002-06-03 2004-01-15 Japan Science & Technology Corp ブロック共重合体とアンスラサイクリン系抗癌剤を含む新規固型製剤及びその製造法
JP2004018494A (ja) * 2002-06-19 2004-01-22 Japan Science & Technology Corp ブロック共重合体−薬剤複合体の製造法
US7495099B2 (en) * 2002-10-31 2009-02-24 Nippon Kayaku Kabushiki Kaisha High-molecular weight derivatives of camptothecins
EP1562641A4 (fr) * 2002-11-07 2008-12-03 Univ Texas Conjugues ethylene dicysteine (ec)-medicament, compositions et procedes d'imagerie de maladies specifiques des tissus
US7045589B2 (en) * 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
CA2518964C (fr) * 2003-03-20 2011-09-13 Nippon Kayaku Kabushiki Kaisha Preparation micellaire contenant un agent anticancereux faiblement soluble dans l'eau, et nouveau copolymere sequence
WO2004105799A1 (fr) * 2003-05-29 2004-12-09 Toudai Tlo, Ltd. Micelle polymere stabilisee
ES2717836T3 (es) * 2003-12-05 2019-06-25 Arrogene Inc Sistema de administración de fármacos multifuncional a base de ácido polimálico
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
ATE458022T1 (de) * 2003-12-10 2010-03-15 Toudai Tlo Ltd Koordinationskomplex von diaminocyclohexanplatin(ii) mit einem blockcopolymer mit einem poly(carbonsäure)segment und diesen enthaltendes antitumormittel
WO2006003731A1 (fr) * 2004-07-05 2006-01-12 Kanagawa Academy Of Science And Technology Agent d'imagerie irm de type micelle polymère
CA2581125C (fr) 2004-09-22 2013-04-23 Nippon Kayaku Kabushiki Kaisha Nouveau copolymere en blocs, preparation de micelles et agent anticancereux contenant celle-ci comme ingredient actif
CA2601546A1 (fr) * 2005-03-31 2006-10-05 Ap Pharma, Inc. Copolymeres dibloc et tribloc de polyethyleneglycol-polyacetal et compositions pharmaceutiques associees
KR101312417B1 (ko) * 2005-05-11 2013-09-27 니폰 가야꾸 가부시끼가이샤 시티딘계 대사길항제의 고분자 유도체
US20060263328A1 (en) * 2005-05-19 2006-11-23 Sang Van Hydrophilic polymers with pendant functional groups and method thereof
PT2656840E (pt) * 2005-06-09 2016-01-20 Univ Tokyo Métodos para produção de compostos de coordenação de complexos de platina
JP5044150B2 (ja) 2005-08-05 2012-10-10 Ｔｏｔｏ株式会社 光照射により薬効を消失させる医薬二酸化チタン複合材
CN101321806B (zh) * 2005-12-05 2011-01-26 日东电工株式会社 聚谷氨酸盐-氨基酸轭合物及方法
US8338562B2 (en) 2005-12-28 2012-12-25 Fresenius Kabi Oncology Limited Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions
US8323669B2 (en) 2006-03-28 2012-12-04 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of taxane
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
EP2011516A4 (fr) * 2006-04-24 2010-06-23 Nanocarrier Co Ltd Procédé de production d'une micelle polymère qui contient un produit chimique de faible poids moléculaire encapsulé en elle
CN101448875A (zh) 2006-05-18 2009-06-03 日本化药株式会社 鬼臼毒素类的高分子量结合体
MX2009003092A (es) * 2006-09-22 2009-05-08 Labopharm Inc Composiciones y metodos para suministro de farmaco dirigido a ph.
CA2664852A1 (fr) * 2006-10-03 2008-04-10 Nippon Kayaku Kabushiki Kaisha Melange d'un derive de resorcinol avec un polymere
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
WO2008056596A1 (fr) * 2006-11-06 2008-05-15 Nippon Kayaku Kabushiki Kaisha Dérivé polymère d'un antagoniste métabolique d'acide nucléique
EP2090607B1 (fr) 2006-11-08 2015-05-20 Nippon Kayaku Kabushiki Kaisha Dérivé polymère d'un antagoniste métabolique d'acide nucléique
US20080181852A1 (en) * 2007-01-29 2008-07-31 Nitto Denko Corporation Multi-functional Drug Carriers
CN101674852A (zh) * 2007-04-10 2010-03-17 日东电工株式会社 多功能聚谷氨酸盐药物载体
US20080279782A1 (en) * 2007-05-09 2008-11-13 Nitto Denko Corporation Polymers conjugated with platinum drugs
US20080279778A1 (en) * 2007-05-09 2008-11-13 Nitto Denko Corporation Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
CN101678123B (zh) 2007-05-09 2014-07-16 日东电工株式会社 包含疏水性化合物和聚氨基酸结合物的组合物
WO2008151019A1 (fr) * 2007-05-30 2008-12-11 University Of Florida Research Foundation, Inc. Libération prolongée de molécules bioactives à partir d'hydrogels de silicone
CA2690244C (fr) 2007-06-26 2016-08-09 Ofra Benny-Ratsaby Polymersomes inhibiteurs de metap-2 destines a l'administration therapeutique
US8075909B2 (en) * 2007-09-04 2011-12-13 University Of Florida Research Foundation, Incorporated Contact lens based bioactive agent delivery system
EP2042538A1 (fr) * 2007-09-18 2009-04-01 Nirvana's Tree House Copolymères amphiphiles et compositions contenant de tels polymères
EP2206502B1 (fr) 2007-09-28 2018-09-12 Nippon Kayaku Kabushiki Kaisha Conjugué polymère-stéroïde
US8440787B2 (en) 2007-10-23 2013-05-14 Nektar Therapeutics Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
MX2010009670A (es) * 2008-03-06 2010-09-22 Nitto Denko Corp Conjugados de paclitaxel polimericos y metodos para tratamiento de cancer.
EP2258397B1 (fr) 2008-03-18 2017-10-11 Nippon Kayaku Kabushiki Kaisha Conjugué de polymère et de substance physiologiquement active
EP2284209B1 (fr) * 2008-05-08 2016-08-31 Nippon Kayaku Kabushiki Kaisha Conjugué de polymère avec l'acide folique ou un dérivé de l'acide folique
ES2396134T3 (es) * 2008-05-23 2013-02-19 Nanocarrier Co., Ltd. Derivado polimérico de docetaxel, método de preparación del mismo y sus usos
JP2011162569A (ja) 2008-05-23 2011-08-25 Nano Career Kk カンプトテシン高分子誘導体及びその用途
WO2010131675A1 (fr) 2009-05-15 2010-11-18 日本化薬株式会社 Conjugue polymere de substance bioactive comprenant un groupe hydroxy
CA2775747A1 (fr) * 2009-10-07 2011-04-14 Sanford Burnham Medical Research Institute Methodes et compositions associees a des composes lipidiques lies au caillot
JP2013514977A (ja) * 2009-12-16 2013-05-02 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 複数の物質の送達のための粒子
CA2791278C (fr) 2010-02-25 2015-11-24 The Johns Hopkins University Delivrance prolongee d'agents therapeutiques a un compartiment oculaire
JP2013525285A (ja) 2010-04-08 2013-06-20 サンフォード−バーナム メディカル リサーチ インスティテュート 化合物の送達を増強するための方法および組成物
CA2816997A1 (fr) 2010-11-17 2012-05-24 Nippon Kayaku Kabushiki Kaisha Nouveau derive polymere d'antagoniste de metabolisme de cytidine
US9327037B2 (en) 2011-02-08 2016-05-03 The Johns Hopkins University Mucus penetrating gene carriers
WO2012118778A1 (fr) 2011-02-28 2012-09-07 Sanford-Burnham Medical Research Institute Peptides car tronqués, procédés et compositions les utilisant
US9504761B2 (en) 2011-04-20 2016-11-29 University Of Central Florida Research Foundation, Inc. Stabilized chitosan-based nanoparticles and methods for making the same
US10179801B2 (en) 2011-08-26 2019-01-15 Sanford-Burnham Medical Research Institute Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
KR101849142B1 (ko) 2011-09-11 2018-04-16 니폰 가야꾸 가부시끼가이샤 블록 공중합체의 제조방법
WO2013138346A1 (fr) 2012-03-16 2013-09-19 The Johns Hopkins University Conjugués copolymère multi-blocs non linéaire-médicament pour l'administration de principes actifs
AU2013232297B2 (en) * 2012-03-16 2016-01-14 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
US9533068B2 (en) 2012-05-04 2017-01-03 The Johns Hopkins University Drug loaded microfiber sutures for ophthalmic application
CN103910875B (zh) * 2012-12-31 2017-06-13 张雅珍 蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用
WO2014124006A1 (fr) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticules pour le suivi de l'imagerie par résonance magnétique et procédés de fabrication et d'utilisation associés
US9352045B2 (en) 2014-06-20 2016-05-31 International Business Machines Corporation Methods and materials for therapeutic delivery
WO2016123125A1 (fr) 2015-01-27 2016-08-04 The Johns Hopkins University Formulations d'hydrogel hypotoniques pour le transport amélioré d'agents actifs au niveau de surfaces muqueuses
US10500246B2 (en) 2015-06-25 2019-12-10 Sanford Burnham Prebys Medical Discovery Institute Compositions for delivery to and treatment of atherosclerotic plaques
WO2017170845A1 (fr) * 2016-03-30 2017-10-05 ナノキャリア株式会社 Copolymère séquencé conjugué à un médicament, copolymère séquencé et procédé de production de copolymère séquencé conjugué à un médicament
TW201737897A (zh) * 2016-03-30 2017-11-01 Nanocarrier Co Ltd 高分子微胞醫藥組成物
WO2018204392A1 (fr) 2017-05-02 2018-11-08 Stanford Burnham Prebys Medical Discovery Institute Peptide liant des monocytes/macrophages associés à une tumeur et procédés d'utilisation associés
WO2019151320A1 (fr) * 2018-01-30 2019-08-08 国立大学法人大阪大学 Agent anticancéreux
CA3127985A1 (fr) 2019-02-04 2020-08-13 University Of Tartu Peptides de liaison a la matrice extracellulaire bi-specifiques et procedes d'utilisation de ceux-ci
CN110483785B (zh) * 2019-07-01 2020-05-19 中山大学 一种三嵌段聚合物、载药纳米胶束、纳米药物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701521A (en) * 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
DE3380726D1 (en) * 1982-06-24 1989-11-23 Japan Chem Res Long-acting composition
CH667874A5 (fr) * 1985-12-19 1988-11-15 Battelle Memorial Institute Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments.
US4780421A (en) * 1986-04-03 1988-10-25 Sclavo Inc. Cleavable labels for use in binding assays
US4988625A (en) * 1988-11-09 1991-01-29 Merck & Co., Inc. Method for determining the functionalization of a solid support
JP2517760B2 (ja) * 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon

Also Published As

Publication number Publication date
JPH02300133A (ja) 1990-12-12
KR920006912B1 (ko) 1992-08-22
EP0397307B1 (fr) 1996-10-30
AU640927B2 (en) 1993-09-09
US5693751A (en) 1997-12-02
EP0397307A3 (fr) 1991-04-10
ES2098247T3 (es) 1997-05-01
DE69029006T2 (de) 1997-03-06
DE69029006D1 (de) 1996-12-05
JP2517760B2 (ja) 1996-07-24
CA2016505C (fr) 2001-02-13
KR900017574A (ko) 1990-12-19
AU5469990A (en) 1990-11-15
US5412072A (en) 1995-05-02
EP0397307A2 (fr) 1990-11-14

Similar Documents

Publication Publication Date Title
CA2016505A1 (fr) Preparation pharmaceutique polymerisee hydrosoluble a poids moleculaire eleve
AU600723B2 (en) Biodegradable microspheres as a carrier for macromolecules
US5529766C1 (en) Contrast agents
US5160745A (en) Biodegradable microspheres as a carrier for macromolecules
AU7992987A (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch
WO1997025052A3 (fr) Compositions contenant du pvp dont le poids moleculaire moyen est de l'ordre de 3000 a 14000 daltons
DE69226950D1 (de) Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt
EP0388954A3 (fr) Dispersions de polymères lyophilisés et utilisation de celles-ci pour la préparation de compositions pharmaceutiques à libération soutenue
NO20001042L (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
CA2104045A1 (fr) Preparation pharmaceutique de polymeres de micelles de type «capture physique»
CA2046830A1 (fr) Systeme d'administration des medicaments comprenant une interaction entre une proteine ou une polypeptide et un polymere hydrophobe biodegradable
EP1607429A3 (fr) Procédé de préparation de dispersions aqueuses de particules polymères solubles dans l'eau
EP1637154A3 (fr) Poudre contenant un principe actif d'un haut poids moléculaire à l'administration par les muqueuses
CA2041044A1 (fr) Formule orale de series polypeptidiques dissociatives pour le gros intestin
RU94038426A (ru) Узко поли- и монодисперсный водорастворимый олигомер, фармацевтический препарат, способ получения олигомера, способ диагностики и/или лечения вирусных инфекций
EP0598337A3 (fr) Compositions pharmaceutiques contenant un médicament une substance polymère reticulée, une huile, et un agent tensioactif.
CA2212309A1 (fr) Formes posologiques orales solides a liberation prolongee de medicaments faiblement solubles dans l'eau
CA2219777A1 (fr) Nanoparticules pour l'administration orale d'agents pharmaceutiques de faible solubilite
EP0392845A3 (fr) Système d'administration de médicaments externe sous forme d'un gel à l'état solide
DE69825769D1 (de) Eingekapselte wasserdispergierbare perfluoroetherpolymere
CA2242618A1 (fr) Compositions contenant du pvp ultrapure dont le poids moleculaire dont le poids moyen est de l'ordre de 7,000 a 12,000 daltons
RU93049678A (ru) Устойчивый водорастворимый ветеринарный препарат и способ его получения

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry